16400 College Blvd.
,
(913) 825-4400
–
Monday - Friday
JCCT Lenexa has served the Kansas City area for more than 20 years. The site is recognized for deep vaccine, Phase I, and First-in-Human experience and has expanded its capabilities across additional therapeutic areas as sponsor needs and investigator relationships have grown.
The 32,000 sq. ft. research facility includes a 34-bed inpatient unit, 13 outpatient exam rooms, an onsite pharmacy and PBMC processing capabilities.
Dr. Kreamer, CMO, leads research across all therapeutic areas. Dr. Fierro, CSO, with 20+ years of dedicated vaccine research experience. Both are dedicated, full-time investigators, supported by additional investigators and clinical resources based on study needs.
Established strengths include vaccines, infectious disease, Phase I, and First-in-Human research. The site also supports a growing range of therapeutic studies, including metabolic, obesity, endocrine, cardiovascular, and other indications. We have a patient database that can support just about any research trial.